| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/17/2002 | US6451604 Polynucleotides; nucleotide sequence and complement; genetic engineering |
| 09/17/2002 | US6451601 Increasing the replicative capacity of normally quiescent cells, such as normal somatic cells, by transient immortalization or transient telomerization, to produce cells suitable for gene therapy |
| 09/17/2002 | US6451597 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins |
| 09/17/2002 | US6451596 Helper adenovirus vectors |
| 09/17/2002 | US6451592 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 09/17/2002 | US6451579 Regulated expression of recombinant proteins using RNA viruses |
| 09/17/2002 | US6451577 Human uridine disphosphate galactose-4-epimerase |
| 09/17/2002 | US6451575 The invention is directed to the family of aggrecan degrading metallo proteases (admps) that exhibit the ability to cleave the aggrecan core protein between amino acid residues glu.sup.373 -ala.sup.374. the invention encompasses the |
| 09/17/2002 | US6451561 Growth hormone variants |
| 09/17/2002 | US6451558 Genes in the control of hematopoiesis |
| 09/17/2002 | US6451554 Purified nucleic acid sequence encoding a sodium channel protein wherein said nucleic acid sequence comprises the coding portion of the nucleic acid sequence and producing a mammalian sensory neuron sodium channel protein, wherein the |
| 09/17/2002 | US6451547 Process for differential diagnosis of Alzheimer's dementia and device therefor |
| 09/17/2002 | US6451546 Plant glurs of the invention may function as signal transducers involved in the regulation of plant growth. the invention also relates to the identification of compounds that modulate the activity of the plant glur and herbicides |
| 09/17/2002 | US6451541 Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPsc |
| 09/17/2002 | US6451539 Expression vectors, transfection systems, and method of use thereof |
| 09/17/2002 | US6451534 Kvlqt1 and kcne1 which are genes associated with long qt syndrome. additional sequence data for the two genes are also disclosed. mutations in kvlqt1 which result in long qt syndrome. the intron/exon junction sequence data allow for the |
| 09/17/2002 | US6451523 Variant form of the receptor for the obese gene product. the invention relates to methods of detecting this receptor variant in cells and tissues of obese individuals. |
| 09/17/2002 | US6451522 Combining agent to be tested, antibody or antigen-binding fragment which binds to amino terminal domain of mammalian cc-chemokine receptor 2, mammalian cc-chemokine receptor 2 or ligand-binding variant, measuring binding |
| 09/17/2002 | US6451323 Recombinant newcastle disease virus RNA expression systems and vaccines |
| 09/17/2002 | US6451316 Incubating t-cells and antigen presenting cells in vitro with purified complex of heat shock protein and antigen; generating cd4 cells; immunotherapy, anticarcinogenic agents |
| 09/17/2002 | US6451315 Compounds and methods for the diagnosis and treatment of B. microti infection |
| 09/17/2002 | US6451313 Heterotetramer; expression vectors encoding heavy and light chains; viricides |
| 09/17/2002 | US6451311 An antibody which binds procalcitonin but not free calcitonin, free katacalcin and free n-procalcitonin; used as an in vitro or in vivo diagnostic agent |
| 09/17/2002 | US6451310 Preventing t cell activation of b cells by administering antibody cabable of binding protein recognized by monoclonal antibody 5c8 |
| 09/17/2002 | US6451305 Methods for stimulating T cell responses to tumor cells expressing LFA-3 and a CD28 or CTLA4 ligand |
| 09/17/2002 | US6451060 Chondrocyte cell culture; overcoating permselective membrane |
| 09/17/2002 | CA2243459C Human antibodies that bind human tnf.alpha. |
| 09/17/2002 | CA2213001C Isolated nucleic acid molecule encoding peptides which form complexes with mhc molecule hla-cw*1601 and uses thereof |
| 09/17/2002 | CA2204151C Cdna encoding a bmp type ii receptor |
| 09/17/2002 | CA2187908C Non-splicing variants of gp350/220 |
| 09/17/2002 | CA2113118C Novel growth factor-responsive progenitor cells which can be proliferated in vitro |
| 09/17/2002 | CA2111853C Substantially pure receptor like tgf-.beta.1 binding molecules and uses thereof |
| 09/17/2002 | CA2095534C Avirulent microbes and uses therefor |
| 09/17/2002 | CA2072420C Storage of materials |
| 09/17/2002 | CA2067919C Heterobifunctional antibodies possessing dual catalytic and specific antigen binding properties and methods using them |
| 09/17/2002 | CA2047244C Genetically engineered immunoglobulins |
| 09/15/2002 | CA2373454A1 Recombinant infectious laryngotracheitis virus vaccine |
| 09/13/2002 | CA2374027A1 Cloning, expression, sequencing, and functional enhancement of monoclonal scfv antibody against venezuelan equine encephalitis virus(vee) |
| 09/12/2002 | WO2002070737A2 Compositions and methods relating to osteoarthritis |
| 09/12/2002 | WO2002070729A2 Improved skin substitutes and uses thereof |
| 09/12/2002 | WO2002070718A1 Dna encoding l-ribose isomerae and use thereof |
| 09/12/2002 | WO2002070717A2 Nitrile hydratase and a method for producing amides |
| 09/12/2002 | WO2002070711A1 Vaccine |
| 09/12/2002 | WO2002070708A2 Glutamate receptor modulatory proteins and nucleic acids encoding them |
| 09/12/2002 | WO2002070706A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | WO2002070703A2 Cell visual characteristic-modifying sequences |
| 09/12/2002 | WO2002070700A1 Polynucleotide useful for modulating cancer cell proliferation |
| 09/12/2002 | WO2002070681A1 Protein c variants |
| 09/12/2002 | WO2002070673A1 Concentration and lysis of adenovirus-infected cells in a single unit operations |
| 09/12/2002 | WO2002070669A2 Secreted proteins |
| 09/12/2002 | WO2002070660A2 Proteins and nucleic acids encoding same |
| 09/12/2002 | WO2002070657A2 93870, a human g-protein coupled receptor and uses therefor |
| 09/12/2002 | WO2002070655A2 Mouse cytokine receptor |
| 09/12/2002 | WO2002070648A2 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 09/12/2002 | WO2002070565A2 High-affinity antagonists of elr-cxc chemokines |
| 09/12/2002 | WO2002070563A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070562A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070561A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070560A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070559A2 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | WO2002070558A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070557A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070556A1 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF |
| 09/12/2002 | WO2002070555A2 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 09/12/2002 | WO2002070553A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 09/12/2002 | WO2002070552A2 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF |
| 09/12/2002 | WO2002070549A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 09/12/2002 | WO2002070024A1 Method for sterilizing bioactive materials |
| 09/12/2002 | WO2002070023A2 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation |
| 09/12/2002 | WO2002070006A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| 09/12/2002 | WO2002069988A2 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and their use in bone marrow transplantation |
| 09/12/2002 | WO2002069976A2 Use of ovarian hormone for increasing neural stem cell number |
| 09/12/2002 | WO2002069947A2 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer |
| 09/12/2002 | WO2002069907A2 Anti-neovasculature preparations for cancer |
| 09/12/2002 | WO2002063010A9 Method of producing recombinant antibodies against tumors |
| 09/12/2002 | WO2002062851A8 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 09/12/2002 | WO2002057409A3 Antisense modulation of src-2 expression |
| 09/12/2002 | WO2002052012A3 Sugar beet genes involved in stress tolerance |
| 09/12/2002 | WO2002051986A3 Educated nk t cells and their uses in the treatment of immune-related disorders |
| 09/12/2002 | WO2002040640A3 Methods of using cd8+/tcr- facilitating cells (fc) for the engraftment of purified hematopoietic stem cells (hsc) |
| 09/12/2002 | WO2002028997A3 Methods of isolating bipotent hepatic progenitor cells |
| 09/12/2002 | WO2002022680A3 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 09/12/2002 | WO2002014369A3 Human kininogen d5 domain polypeptides and their use |
| 09/12/2002 | WO2002012465A3 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 09/12/2002 | WO2002012462A3 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
| 09/12/2002 | WO2002010351A3 Autologous connective tissues, methods for the production thereof and their use |
| 09/12/2002 | WO2002007748A3 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 09/12/2002 | WO2001092543A3 Improved methods of transfection |
| 09/12/2002 | WO2001083529A3 Immunoadhesin for the prevention of rhinovirus infection |
| 09/12/2002 | WO2001077335A3 Listeria monocytogenes genome, polypeptides and uses |
| 09/12/2002 | WO2001048147A9 Cell culture medium containing growth factors and l-glutamine |
| 09/12/2002 | WO2001046384A3 A method for isolating and purifying multipotential neural progenitor cells and multipotential neural progenitor cells |
| 09/12/2002 | WO2001038509A9 Method for the mutagenesis of nucleotide sequences from plants algae or fungi |
| 09/12/2002 | WO2001036626A9 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 09/12/2002 | WO2001030848A3 Nucleic acids of the human abc1 gene and applications thereof |
| 09/12/2002 | WO2001018175A9 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 09/12/2002 | WO2001016183A9 Monoclonal antibodies and vaccines against epitopes on the ebola virus glycoprotein |
| 09/12/2002 | WO2001010203A3 Non-human transgenic animals for the study of neurodegenerative syndromes |
| 09/12/2002 | WO2001009192A9 Human monoclonal antibodies to prostate specific membrane antigen |
| 09/12/2002 | WO2001002609A3 Method of identifying toxic agents using differential gene expression |